These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


313 related items for PubMed ID: 20194446

  • 1. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
    Cai X, Yang X, Lian F, Lin X, Liang M, Li J, Chen X, Liang L, Qin S, Fu J.
    J Rheumatol; 2010 Apr; 37(4):759-65. PubMed ID: 20194446
    [Abstract] [Full Text] [Related]

  • 2. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 02; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 4. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 02; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 5. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 6. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
    Nephrol Dial Transplant; 2006 Nov 13; 21(11):3115-21. PubMed ID: 16877491
    [Abstract] [Full Text] [Related]

  • 7. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun 13; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
    Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, Fabien N.
    Lupus; 2011 Jan 13; 20(1):28-34. PubMed ID: 20943718
    [Abstract] [Full Text] [Related]

  • 9. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
    Gunnarsson I, Sundelin B, Heimbürger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH.
    J Rheumatol; 2002 Apr 13; 29(4):693-9. PubMed ID: 11950009
    [Abstract] [Full Text] [Related]

  • 10. Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.
    Yang XW, Tan Y, Yu F, Zhao MH.
    Nephrol Dial Transplant; 2012 Sep 13; 27(9):3552-9. PubMed ID: 22700716
    [Abstract] [Full Text] [Related]

  • 11. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.
    Arthritis Rheum; 2011 Aug 13; 63(8):2436-44. PubMed ID: 21506094
    [Abstract] [Full Text] [Related]

  • 12. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC, Wang CR, Liu MF, Chen FF, Liang CC.
    Asian Pac J Allergy Immunol; 2002 Dec 13; 20(4):223-7. PubMed ID: 12744622
    [Abstract] [Full Text] [Related]

  • 13. Anti-C1q antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephritis.
    Chen Z, Wang GS, Wang GH, Li XP.
    Clin Rheumatol; 2012 Sep 13; 31(9):1323-9. PubMed ID: 22696012
    [Abstract] [Full Text] [Related]

  • 14. Anti-C1q autoantibodies in lupus nephritis.
    Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G.
    Ann N Y Acad Sci; 2009 Sep 13; 1173():47-51. PubMed ID: 19758131
    [Abstract] [Full Text] [Related]

  • 15. Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.
    Radanova M, Vasilev V, Deliyska B, Kishore U, Ikonomov V, Ivanova D.
    Immunobiology; 2012 Jul 13; 217(7):684-91. PubMed ID: 22209113
    [Abstract] [Full Text] [Related]

  • 16. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis.
    Tan Y, Zhou W, Yu F, Fang Q, Yang HZ, Zhao MH.
    Mol Immunol; 2009 Jul 13; 46(11-12):2178-82. PubMed ID: 19481805
    [Abstract] [Full Text] [Related]

  • 17. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
    Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M.
    Lupus; 2011 Oct 13; 20(12):1267-74. PubMed ID: 21813587
    [Abstract] [Full Text] [Related]

  • 18. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
    Moura CG, Mangueira CL, Cruz LA, Cruz CM.
    Nephron Clin Pract; 2011 Oct 13; 118(4):c355-60. PubMed ID: 21325866
    [Abstract] [Full Text] [Related]

  • 19. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
    Hung WT, Chen YM, Lan JL, Chen HH, Chen YH, Chen DY, Hsieh CW, Wen MC.
    Lupus; 2011 Nov 13; 20(13):1404-10. PubMed ID: 21946514
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone.
    Grootscholten C, Dieker JW, McGrath FD, Roos A, Derksen RH, van der Vlag J, Daha MR, Berden JH.
    Ann Rheum Dis; 2007 May 13; 66(5):693-6. PubMed ID: 17135217
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.